The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
Robert W. Robey(National Cancer Institute), Pedro J. Batista(National Institutes of Health)
Cited by 15
Related Papers
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
|NAR Cancer|2024|11
The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|5
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0